Skip to main content
Veterinary Medicines

Mastisan PN DC (300 000 j.m. + 150 000 j.m.)/5 g Zawiesina dowymieniowa

Authorised
  • Benzylpenicillin procaine
  • NEOMYCIN SULFATE

Product identification

Medicine name:
Mastisan PN DC (300 000 j.m. + 150 000 j.m.)/5 g Zawiesina dowymieniowa
Active substance:
  • Benzylpenicillin procaine
  • NEOMYCIN SULFATE
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Benzylpenicillin procaine
    300000.00
    international unit(s)
    /
    5.00
    gram(s)
  • NEOMYCIN SULFATE
    150000.00
    international unit(s)
    /
    5.00
    gram(s)
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        45
        day
      • Milk
        8
        day
      • Milk
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC23
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vet-Agro Multi-Trade Company Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Multi-Trade Company "Vet-Agro" Sp. z o.o.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0060
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."